21 February 2017
News and Views
Links and Services
A study in December's issue of the American Journal of Gastroenterology examines the risk of cancer IBD according to patient phenotype and treatment.
Population-based studies of site-specific cancer risk in patients with inflammatory bowel disease
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors